Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

New findings add weight to the theory that COVID-19 originated at the Wuhan Institute of Virology. Experts point to lax ...

Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an important connection for rheumatologists as they sort through symptoms and ...

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

Shi Zhengli, a leading virologist, became known as “Bat Woman” for her work on coronaviruses. She has spent decades studying ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long-COVID continues to impact many, with symptoms lasting years in some cases.

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years ...

The German parliament's oversight committee has called on the government to share the findings of an investigation into the ...

Five years ago this month, Britain entered its first Covid lockdown. Streets were emptied, families separated and the NHS ...

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to ...